{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:28Z","timestamp":1790724088536,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jinf.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:49:57Z","timestamp":1244792997000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Increasing extended-spectrum \u03b2-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia\/Pacific region: Data from the Smart Study 2002\u20132006"],"prefix":"10.1016","volume":"59","author":[{"given":"Wen-Chien","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2009.06.003_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/sur.2005.6.439","article-title":"In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"6","author":"Chow","year":"2005","journal-title":"Surg Infect"},{"key":"10.1016\/j.jinf.2009.06.003_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki117","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"55","author":"Paterson","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.06.003_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jac\/dkl199","article-title":"In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)","volume":"58","author":"Rossi","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijantimicag.2006.04.010","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia\u2013Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)","volume":"28","author":"Hsueh","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2009.06.003_bib5","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2007"},{"key":"10.1016\/j.jinf.2009.06.003_bib6","series-title":"Performance standards for antimicrobial susceptibility testing: 16th informational supplement","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2007"},{"key":"10.1016\/j.jinf.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijantimicag.2004.08.008","article-title":"Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates","volume":"24","author":"Nijssen","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2009.06.003_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01228-08","article-title":"Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy","volume":"53","author":"Yagci","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.06.003_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1345\/aph.1L473","article-title":"Comparison of 2002\u20132006 OPTAMA programs for US hospitals: focus on Gram-negative resistance","volume":"43","author":"Crandon","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jinf.2009.06.003_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1086\/592703","article-title":"Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance","volume":"30","author":"Lautenbach","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","article-title":"Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation","volume":"52","author":"Tanimoto","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.06.003_bib13","first-page":"69","article-title":"Aeromonas infection in acute suppurative cholangitis: review of 30 cases","volume":"40","author":"Chan","year":"2000","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jinf.2009.06.003_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0463.2006.apm_470.x","article-title":"Secondary Aeromonas peritonitis is associated with polymicrobial ascites culture and absence of liver cirrhosis compared to primary Aeromonas peritonitis","volume":"114","author":"Huang","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.jinf.2009.06.003_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/jac\/dkg247","article-title":"Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of \u03b2-lactamase expression in Aeromonas spp","volume":"51","author":"Niumsup","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.06.003_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jinf.2006.04.002","article-title":"Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan","volume":"54","author":"Wu","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/378702","article-title":"Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections","volume":"37","author":"Solomkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijantimicag.2007.03.002","article-title":"Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia","volume":"30","author":"Hsueh","year":"2007","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:12:36Z","timestamp":1759007556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445309001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0163445309001613"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2009.06.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing extended-spectrum \u03b2-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia\/Pacific region: Data from the Smart Study 2002\u20132006","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2009.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}